West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
213.06
-1.68 (-0.78%)
At close: May 9, 2025, 4:00 PM
205.88
-7.18 (-3.37%)
After-hours: May 9, 2025, 7:42 PM EDT

WST Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
2,8962,8932,9502,8872,8322,147
Upgrade
Revenue Growth (YoY)
-1.12%-1.92%2.18%1.95%31.89%16.69%
Upgrade
Cost of Revenue
1,8961,8951,8201,7511,6541,379
Upgrade
Gross Profit
1,000998.51,1301,1361,178767.8
Upgrade
Selling, General & Admin
334.8334.9354.1316356.3300.8
Upgrade
Research & Development
67.869.168.458.552.846.9
Upgrade
Other Operating Expenses
0.90.91.3-2.1--2.5
Upgrade
Operating Expenses
403.5404.9423.8372.4409.1345.2
Upgrade
Operating Income
596.7593.6706.2763.8768.6422.6
Upgrade
Interest Expense
-1.8-3-9-7.9-8.2-8.2
Upgrade
Interest & Investment Income
17.519.6285.111.4
Upgrade
Earnings From Equity Investments
13.814.717.720.720.117.4
Upgrade
Currency Exchange Gain (Loss)
-10.2-10.2-9.44.11.41.5
Upgrade
EBT Excluding Unusual Items
615.8614.7733.5785.8782.9434.7
Upgrade
Merger & Restructuring Charges
-19.9-2.12-23.8-2.2-4.6
Upgrade
Gain (Loss) on Sale of Investments
-0.3-0.3-4.3-3.5-4.3-2.5
Upgrade
Gain (Loss) on Sale of Assets
---11.6---
Upgrade
Asset Writedown
-6.7-7-5.3-2.7-4.1-7.7
Upgrade
Legal Settlements
--3.8---
Upgrade
Other Unusual Items
-6.5-5.1-2.4-55.2-3.3-1.2
Upgrade
Pretax Income
582.4600.2715.7700.6769418.7
Upgrade
Income Tax Expense
115.2107.5122.3114.7107.272.5
Upgrade
Net Income
467.2492.7593.4585.9661.8346.2
Upgrade
Net Income to Common
467.2492.7593.4585.9661.8346.2
Upgrade
Net Income Growth
-17.85%-16.97%1.28%-11.47%91.16%43.23%
Upgrade
Shares Outstanding (Basic)
737374747474
Upgrade
Shares Outstanding (Diluted)
737475767676
Upgrade
Shares Change (YoY)
-2.10%-2.13%-0.66%-0.66%0.66%0.53%
Upgrade
EPS (Basic)
6.426.757.997.888.904.68
Upgrade
EPS (Diluted)
6.376.697.887.738.674.57
Upgrade
EPS Growth
-15.97%-15.10%1.94%-10.84%89.72%42.37%
Upgrade
Free Cash Flow
306.9276.4414.5439.4330.6298.1
Upgrade
Free Cash Flow Per Share
4.183.755.505.804.333.93
Upgrade
Dividend Per Share
0.8200.8100.7700.7300.6900.650
Upgrade
Dividend Growth
5.13%5.20%5.48%5.80%6.15%6.56%
Upgrade
Gross Margin
34.54%34.51%38.31%39.36%41.59%35.76%
Upgrade
Operating Margin
20.61%20.52%23.94%26.46%27.14%19.68%
Upgrade
Profit Margin
16.13%17.03%20.12%20.29%23.37%16.13%
Upgrade
Free Cash Flow Margin
10.60%9.55%14.05%15.22%11.68%13.88%
Upgrade
EBITDA
756.5749843.5884.4890.9531.7
Upgrade
EBITDA Margin
26.12%25.89%28.59%30.64%31.46%24.77%
Upgrade
D&A For EBITDA
159.8155.4137.3120.6122.3109.1
Upgrade
EBIT
596.7593.6706.2763.8768.6422.6
Upgrade
EBIT Margin
20.61%20.52%23.94%26.46%27.14%19.68%
Upgrade
Effective Tax Rate
19.78%17.91%17.09%16.37%13.94%17.32%
Upgrade
Updated Apr 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q